Pfizer’s (PFE) 4Q adjusted EPS came in at $0.10 versus an estimated -$0.19 and revenue came in at $14.25B versus an estimated $14.36B. Lee Bohl and Sel Hardy discuss the takeaways from Pfizer’s earnings. They talk about how Pfizer can succeed in a post-pandemic world. Tune in to find out more about the stock market today.